Abraham N. Ceesay
CEO, President, Treasurer & DirectorMr. Abraham N. Ceesay, also known as Abe, MBA, is Director at Charles River Laboratories International Inc. Since May 20, 2025. serves as the Chief Executive Officer and President at Rapport Therapeutics, Inc. since February 2023 and serves as its Treasurer and serves as its Director since March 2023. He served as Independent Director at Pacira BioSciences, Inc. since October 10, 2023 until May 2026. He served as President at Cerevel Therapeutics Holdings, Inc. since May 3, 2021 until March 09, 2023. He was the Chief Operating Officer at scPharmaceuticals Inc. (alternate name: scPharmaceuticals LLC) since joining it in March 2016 until October 19, 2018. Mr. Ceesay has an extensive experience in the launch and growth of innovative therapeutic products and a strong track record in the leadership of global commercial teams. Mr. Ceesay served as the Vice President of Sales, Marketing and Commercial Operations at Keryx Biopharmaceuticals Inc. from 2014 to March 25, 2016. Mr. Ceesay served as the Vice President of Marketing & Operations at Keryx Biopharmaceuticals Inc. since February 18, 2014 and also served as its Vice President, Sales, Marketing and Commercial Operations from 2014 to 2016, where he developed the commercial organization and strategy for its inaugural product Auryxia. He serves on the Board of Directors for Life Science Cares and Camp Harbor View. He served as the Chief Executive Officer at Tiburio Therapeutics From January 2019 until April 2021. Mr. Ceesay developed and led all aspects of the Zerenex(TM) launch strategy and execution, including brand planning, forecasting and analysis, marketing operations and patient access programs. Mr. Ceesay served as the Vice President of Marketing at Ironwood Pharmaceuticals from 2010 to 2014, where he held responsibility for the management of the U.S. P&L, leadership of the Linzess(R) brand team and co-promotion collaboration with Forest Laboratories. In his role, Mr. Ceesay developed and led all facets of the Linzess(R) launch strategy and also led the cross functional U.S. Operating Team responsible for the commercial and development decisions to support the commercialization of Linzess(R). Previous to his career with Ironwood, from 2002 to 2010, Mr. Ceesay served at Genzyme/Sanofi, initially as a field sales specialist and ultimately as the Director, Renal Global Marketing, in which capacity he held marketing responsibility for its renal franchise (Renagel(R), Renvela(R), Hectorol(R)). Over the course of his career at Genzyme, Mr. Ceesay developed and implemented brand strategies for the global renal franchise, including all marketing facets of the Renvela(R) launch strategy. He is on the Board of Trustees at The Museum of Science in Boston, Massachusetts. Mr. Ceesay holds a B.S. in Health Education & Physiology from Ithaca College and a Master of Business Administration from Suffolk University's Sawyer School of Management.
Positions
- Company NameRapport Therapeutics, Inc.Stock CodeRAPPPositionCEO, President, Treasurer & DirectorColleagues
